Monday, March 12, 2007

FDA Approves Cymbalta for Treatment of Generalized Anxiety Disorder



Phramalive.com - peripheral neuropathic pain and generalized anxiety disorder. In children and teens, antidepressants can increase the risk of suicidal thoughts or actions. Patients should call their doctor right away if they experience worsening depression symptoms
Source: www.pharmalive.com


Click here for more information about overcoming anxiety attacks